On the heels of disappointing results for thalidomide as a treatment for bone marrow cancer, a smaller study suggests the drug may prolong survival of elderly patients, but at a price.In people over ...

Treatment with thalidomide led to a reduction in bleeding among patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), a randomized trial showed. In 150 patients, 68.6% of ...

March 10, 2008 — Adding thalidomide to topotecan appears to improve response rates in patients with recurrent epithelial ovarian carcinoma, according to the results of a phase 2 trial that appear in ...

Chemotherapy-associated nausea and vomiting impairs the quality of life in many patients with cancer. Several clinical trials have demonstrated that corticosteroids, serotonin (5-HT 3) receptor ...

Two years ago, we reported that the incorporation of thalidomide into high-dose therapy for myeloma increased the frequency of complete remission but not the duration of remission and extended ...

March 8, 2005 — Pancreatic cancer patients with cachexia may benefit from thalidomide, according to the results of a randomized study published in the April issue of Gut. "Proinflammatory cytokines, ...

Recurrent bleeding from the small intestine accounts for 5 to 10% of cases of gastrointestinal bleeding and remains a therapeutic challenge. Thalidomide has been evaluated for the treatment of ...

LONDON (Reuters) - Half a century after the launch of the notorious morning sickness pill thalidomide, its surviving victims are demanding 4 billion euros ($6.3 billion) in compensation from the ...

Tánaiste Simon Harris has said 2026 "has to be the year" when the Government finally resolves the outstanding issues facing the Irish Thalidomide Association, including a State apology.

Chemotherapy-associated nausea and vomiting impairs the quality of life in many patients with cancer. Several clinical trials have demonstrated that corticosteroids, serotonin (5-HT 3) receptor ...